Fibre 4 with Probiotics
Natural health product licensed in Canada
- Other names
- Fibre4, The Right Fibre 4
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80105585
- Status
- Active licence
- Licence date
- 22 October 2020
- Revision date
- 27 July 2023
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gomme de Guar partiellement hydrolysée Source : Partially hydrolysed guar gum | 1.25 g | Not calculated |
| Bifidobacterium longum subsp. longum Source : BB-536 | 0.25 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 0.25 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Fécule de manioc, Phosphate de tricalcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 8 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fiber for the maintenance of healthy gastrointestinal functions. Helps to improve intestinal regularity including constipation and/or diarrhea. Helps to improve bowel regularity in people with Irritable Bowel Syndrome (IBS). Helps to relieve constipation and mild gastrointestinal discomfort in people with Irritable Bowel Syndrome (IBS). Helps to reduce the frequency of bowel irregularity and minor gastrointestinal symptoms associated with Irritable Bowel Syndrome (IBS) including flatulence, bloating, dyspepsia and altered bowel habits. Helps to relieve bowel irregularity, bloating, dyspepsia and other minor gastrointestinal symptoms in people with Irritable Bowel Syndrome (IBS). Helps to improve intestinal regularity in children. Helps modulate stool conditions (from either loose or hard) to normal conditions. Helps reduce the need for laxative use. Helps reduce incidents of diarrhea. Helps reduce glycemic response and glycemic index when taken with food . Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of dietary fibre.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80105585
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging